Lisa E. Wang
Icahn School of Medicine at Mount Sinai · 341 works · 8,043 citations · h-index 50
Top works
- Blood in the Belly: CT Findings of Hemoperitoneum
- Evolution of the Randomized Controlled Trial in Oncology Over Three Decades
- Dimorphic effects of Notch signaling in bone homeostasis
- Catalytic asymmetric dihydroxylation of cis-disubstituted olefins
- Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial
- A comparison of estimates of glomerular filtration in critically ill patients with augmented renal clearance
- Metastatic basal cell carcinoma: Prognosis dependent on anatomic site and spread of disease
- Safety of Bevacizumab in Patients With Non–Small-Cell Lung Cancer and Brain Metastases
- Smoking and Lung Cancer Risk in American and Japanese Men: An International Case-Control Study
- Reporting of Serious Adverse Drug Reactions of Targeted Anticancer Agents in Pivotal Phase III Clinical Trials
- Treatment Outcomes by Tumor Histology in Eastern Cooperative Group Study E4599 of Bevacizumab with Paclitaxel/Carboplatin for Advanced Non-small Cell Lung Cancer
- Disclosure of Conflicts of Interest by Authors of Clinical Trials and Editorials in Oncology
- Fast Fourier transform convolution calculations of x‐ray isodose distributions in homogeneous media
- Potential Drug Interactions in Cancer Patients Receiving Supportive Care Exclusively
- A transcript map of the Down syndrome critical region on chromosome 21
- Adavosertib plus gemcitabine for platinum-resistant or platinum-refractory recurrent ovarian cancer: a double-blind, randomised, placebo-controlled, phase 2 trial
- Sickle Cell Disease in Children
- Association of Ipilimumab With Safety and Antitumor Activity in Women With Metastatic or Recurrent Human Papillomavirus–Related Cervical Carcinoma
- Hyperprogressive disease in early‐phase immunotherapy trials: Clinical predictors and association with immune‐related toxicities
- Expression analysis of 6p22 genomic gain in retinoblastoma